Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Renal Function”

279 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 279 results

Large-scale testing (Phase 3)Study completedNCT05425719
What this trial is testing

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Who this might be right for
Chronic Kidney Disease
MediBeacon 249
Early research (Phase 1)Study completedNCT01393964
What this trial is testing

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 35
Early research (Phase 1)Study completedNCT03186495
What this trial is testing

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone DeficiencyGrowth Hormone Deficiency in Children
Novo Nordisk A/S 44
Early research (Phase 1)Study completedNCT02020434
What this trial is testing

The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

Who this might be right for
Subjects With Varying Degrees of Renal Insufficiency andSubjects With Normal Renal Function
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 32
Not applicableUnknownNCT03364504
What this trial is testing

Biological Collection of Kidney Cells

Who this might be right for
Pseudoxanthoma Elasticum
University Hospital, Angers 10
Not applicableStudy completedNCT05414721
What this trial is testing

The Effects of Low Flow and Normal Flow Desflurane Anesthesia

Who this might be right for
AnesthesiaLiver FunctionsKidney Functions+1 more
Yuzuncu Yil University 60
Early research (Phase 1)Study completedNCT04056455
What this trial is testing

Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

Who this might be right for
Renal ImpairmentHealthy Volunteers
Millennium Pharmaceuticals, Inc. 26
Not applicableStudy completedNCT04069871
What this trial is testing

Transcutaneous Electrical Nerve Stimulation for Tissues Perfusion

Who this might be right for
Renal Function DisorderCritical IllnessCritical Illness Myopathy
Assiut University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Early research (Phase 1)Looking for participantsNCT07141030
What this trial is testing

Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Obesity/Overweight
Gan & Lee Pharmaceuticals. 32
Early research (Phase 1)Study completedNCT01830816
What this trial is testing

Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment

Who this might be right for
Multiple MyelomaAdvanced Solid Tumors
Millennium Pharmaceuticals, Inc. 41
Early research (Phase 1)Study completedNCT01904214
What this trial is testing

A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT00482599
What this trial is testing

Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 30
Early research (Phase 1)Study completedNCT00791401
What this trial is testing

The Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

Who this might be right for
SchizophreniaRenal Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Early research (Phase 1)Study completedNCT06586216
What this trial is testing

Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.

Who this might be right for
COVID-19
Pfizer 16
Early research (Phase 1)Study completedNCT04476849
What this trial is testing

Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 27
Early research (Phase 1)Study completedNCT00003368
What this trial is testing

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02603497
What this trial is testing

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Who this might be right for
Patients With Impaired Renal Function
Astellas Pharma Inc 31
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Not applicableEnded earlyNCT00001978
What this trial is testing

Determination of Kidney Function

Who this might be right for
Kidney DiseaseProteinuriaAutoimmune / Connective Tissue Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 456
Load More Results